UMediC Group Bhd
KLSE:UMC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.57
1.03
|
| Price Target |
|
We'll email you a reminder when the closing price reaches MYR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
UMediC Group Bhd
Cost of Revenue
UMediC Group Bhd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
U
|
UMediC Group Bhd
KLSE:UMC
|
Cost of Revenue
-myr31.9m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
Agape ATP Corp
NASDAQ:ATPC
|
Cost of Revenue
-$519.4k
|
CAGR 3-Years
-23%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
P
|
Pharmaniaga Bhd
KLSE:PHARMA
|
Cost of Revenue
-myr3.2B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
UMediC Group Bhd
Glance View
UMedic Group Bhd.is an investment holding company, which engages in the marketing and distribution of medical devices and consumables through its subsidiaries. The company is headquartered in Penang, Pulau Pinang. The company went IPO on 2022-07-26. The Company, through its subsidiaries, is principally involved in marketing, distribution and manufacturing of medical devices as well as the provision of aftersales service. The company is also developing, manufacturing and marketing of medical consumables, namely HydroX series prefilled humidifiers. Its products include Patient monitor / MRI-compatible patient monitor, Defibrillator/AED, General anaesthesia machine, Ventilator, Maternal and infant care, Ultrasound machine, Electric-powered three dimensional (3D) chest compressor, and Furniture’s such as medical bed, medical cart, Pressure transducer kit, Arterial cannulation, Arterial blood sampling systems, and Central venous catheter. The firm markets and distributes its products to more than 400 customers comprising public and private hospitals, other healthcare service providers such as medical centers and other healthcare-related facilities, as well as non-hospitals.
See Also
What is UMediC Group Bhd's Cost of Revenue?
Cost of Revenue
-31.9m
MYR
Based on the financial report for Jul 31, 2024, UMediC Group Bhd's Cost of Revenue amounts to -31.9m MYR.
What is UMediC Group Bhd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-24%
Over the last year, the Cost of Revenue growth was -20%. The average annual Cost of Revenue growth rates for UMediC Group Bhd have been -14% over the past three years , -24% over the past five years .
You don't have any saved screeners yet
